{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:18:46Z","timestamp":1788718726397,"version":"build-2803163510"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06009-1","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:12:04Z","timestamp":1781773924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alzheimer\u2019s Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies"],"prefix":"10.1007","volume":"63","author":[{"given":"Mohd","family":"Kashif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-6430","authenticated-orcid":false,"given":"Dhriti","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"6009_CR1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","volume":"19","author":"A Gustavsson","year":"2023","unstructured":"Gustavsson A, Norton N, Fast T et al (2023) Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement 19:658\u2013670","journal-title":"Alzheimers Dement"},{"key":"6009_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R et al (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8:248","journal-title":"Signal Transduct Target Ther"},{"key":"6009_CR3","doi-asserted-by":"crossref","unstructured":"Pluta R, Ulamek-Koziol M (2020) Tau protein-targeted therapies in Alzheimer\u2019s disease: current state and future perspectives. Alzheimer\u2019s disease: drug discovery. Exon Publications, pp 69\u201382","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch4"},{"key":"6009_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1158204","author":"Z Li","year":"2023","unstructured":"Li Z, Cao Y, Pei H et al (2023) The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer\u2019s disease and the potential countermeasure. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2023.1158204","journal-title":"Front Neurosci"},{"key":"6009_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.gde.2016.04.006","volume":"38","author":"E Area-Gomez","year":"2016","unstructured":"Area-Gomez E, Schon EA (2016) Mitochondria-associated ER membranes and Alzheimer disease. Curr Opin Genet Dev 38:90\u201396","journal-title":"Curr Opin Genet Dev"},{"key":"6009_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2023.102757","volume":"113","author":"P Garcia-Casas","year":"2023","unstructured":"Garcia-Casas P, Rossini M, Filadi R et al (2023) Mitochondrial Ca2+ signaling and Alzheimer\u2019s disease: too much or too little? Cell Calcium 113:102757","journal-title":"Cell Calcium"},{"key":"6009_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122552","volume":"9","author":"NS Leal","year":"2020","unstructured":"Leal NS, Dentoni G, Schreiner B et al (2020) Amyloid \u03b2-peptide increases mitochondria-endoplasmic reticulum contact altering mitochondrial function and autophagosome formation in Alzheimer\u2019s disease-related models. Cells 9:2552","journal-title":"Cells"},{"key":"6009_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1474043","author":"S Safiri","year":"2024","unstructured":"Safiri S, Ghaffari Jolfayi A, Fazlollahi A et al (2024) Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med. https:\/\/doi.org\/10.3389\/fmed.2024.1474043","journal-title":"Front Med"},{"key":"6009_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789","journal-title":"Molecules"},{"key":"6009_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J et al (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 9:211","journal-title":"Signal Transduct Target Ther"},{"key":"6009_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2024.10.014","author":"RJ Castellani","year":"2024","unstructured":"Castellani RJ, Jamshidi P, Plascencia-Villa G et al (2024) The amyloid cascade hypothesis. Am J Pathol. https:\/\/doi.org\/10.1016\/j.ajpath.2024.10.014","journal-title":"Am J Pathol"},{"key":"6009_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-180802","volume":"68","author":"G Paroni","year":"2019","unstructured":"Paroni G, Bisceglia P, Seripa D (2019) Understanding the amyloid hypothesis in Alzheimer\u2019s disease. J Alzheimers Dis 68:493\u2013510","journal-title":"J Alzheimers Dis"},{"key":"6009_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Del Tredici K et al (2021) Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia 17:115\u2013124","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"6009_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00025","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00025","journal-title":"Front Neurosci"},{"key":"6009_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01124-2","volume":"14","author":"E McDade","year":"2022","unstructured":"McDade E, Cummings JL, Dhadda S et al (2022) Lecanemab in patients with early Alzheimer\u2019s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study. Alzheimers Res Ther 14:191","journal-title":"Alzheimers Res Ther"},{"key":"6009_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","volume":"20","author":"G Yadollahikhales","year":"2023","unstructured":"Yadollahikhales G, Rojas JC (2023) Anti-amyloid immunotherapies for Alzheimer\u2019s disease: a 2023 clinical update. Neurotherapeutics 20:914\u2013931","journal-title":"Neurotherapeutics"},{"key":"6009_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2021.102453","volume":"98","author":"D Lim","year":"2021","unstructured":"Lim D, Dematteis G, Tapella L et al (2021) Ca2+ handling at the mitochondria-ER contact sites in neurodegeneration. Cell Calcium 98:102453","journal-title":"Cell Calcium"},{"key":"6009_CR18","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1007\/s12035-024-03971-6","volume":"61","author":"VH Sathyamurthy","year":"2024","unstructured":"Sathyamurthy VH, Nagarajan Y, Parvathi VD (2024) Mitochondria-endoplasmic reticulum contact sites (MERCS): a new axis in neuronal degeneration and regeneration. Mol Neurobiol 61:6528\u20136538","journal-title":"Mol Neurobiol"},{"key":"6009_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41418-020-00705-8","volume":"28","author":"EL Wilson","year":"2021","unstructured":"Wilson EL, Metzakopian E (2021) ER-mitochondria contact sites in neurodegeneration: genetic screening approaches to investigate novel disease mechanisms. Cell Death Differ 28:1804\u20131821","journal-title":"Cell Death Differ"},{"key":"6009_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102320","volume":"98","author":"T Jiang","year":"2024","unstructured":"Jiang T, Ruan N, Luo P et al (2024) Modulation of ER-mitochondria tethering complex VAPB-PTPIP51: novel therapeutic targets for aging-associated diseases. Ageing Res Rev 98:102320","journal-title":"Ageing Res Rev"},{"key":"6009_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105020","volume":"143","author":"DHW Lau","year":"2020","unstructured":"Lau DHW, Paillusson S, Hartopp N et al (2020) Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer\u2019s disease brain. Neurobiol Dis 143:105020","journal-title":"Neurobiol Dis"},{"key":"6009_CR22","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3233\/JAD-230389","volume":"96","author":"K Li","year":"2023","unstructured":"Li K, Rashid T, Li J et al (2023) Postmortem brain imaging in Alzheimer\u2019s disease and related dementias: the South Texas Alzheimer\u2019s Disease Research Center repository. J Alzheimers Dis 96:1267\u20131283","journal-title":"J Alzheimers Dis"},{"key":"6009_CR23","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1007\/s12035-023-03858-y","volume":"61","author":"C Gao","year":"2024","unstructured":"Gao C, Shang J, Sun Z et al (2024) Presenilin2 D439A mutation induces dysfunction of mitochondrial fusion\/fission dynamics and abnormal regulation of GTPase activity. Mol Neurobiol 61:5047\u20135070","journal-title":"Mol Neurobiol"},{"key":"6009_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.629522","author":"U Ahumada-Castro","year":"2021","unstructured":"Ahumada-Castro U, Bustos G, Silva-Pavez E et al (2021) In the right place at the right time: regulation of cell metabolism by IP3R-mediated inter-organelle Ca2+ fluxes. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.629522","journal-title":"Front Cell Dev Biol"},{"key":"6009_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2524832","author":"Z Yin","year":"2022","unstructured":"Yin Z, Gao D, Du K et al (2022) Rhein ameliorates cognitive impairment in an APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease by relieving oxidative stress through activating the SIRT1\/PGC\u20101 \u03b1 pathway. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/2524832","journal-title":"Oxid Med Cell Longev"},{"key":"6009_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081967","volume":"10","author":"A Jullienne","year":"2022","unstructured":"Jullienne A, Quan R, Szu JI et al (2022) Progressive vascular abnormalities in the aging 3xTg-AD mouse model of Alzheimer\u2019s disease. Biomedicines 10:1967","journal-title":"Biomedicines"},{"key":"6009_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081111","volume":"12","author":"J Panes","year":"2023","unstructured":"Panes J, Nguyen TKO, Gao H et al (2023) Partial inhibition of complex I restores mitochondrial morphology and mitochondria-ER communication in hippocampus of APP\/PS1 mice. Cells 12:1111","journal-title":"Cells"},{"key":"6009_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02911-1","volume":"11","author":"G Dematteis","year":"2020","unstructured":"Dematteis G, Vydmantait\u0117 G, Ruffinatti FA et al (2020) Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice. Cell Death Dis 11:645","journal-title":"Cell Death Dis"},{"key":"6009_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122552","volume":"9","author":"NS Leal","year":"2020","unstructured":"Leal NS, Dentoni G, Schreiner B et al (2020) Amyloid \u03b2-peptide increases mitochondria-endoplasmic reticulum contact altering mitochondrial function and autophagosome formation in Alzheimer\u2019s disease-related models. Cells 9:2552","journal-title":"Cells"},{"key":"6009_CR30","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1038\/emboj.2012.202","volume":"31","author":"E Area-Gomez","year":"2012","unstructured":"Area-Gomez E, del Carmen Lara Castillo M, Tambini MD et al (2012) Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J 31:4106\u20134123","journal-title":"EMBO J"},{"key":"6009_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00772-2","volume":"19","author":"KA Walker","year":"2024","unstructured":"Walker KA, An Y, Moghekar A et al (2024) Proteomic analysis of APOE\u03b54 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience. Mol Neurodegener 19:81","journal-title":"Mol Neurodegener"},{"key":"6009_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010778","volume":"24","author":"M Pires","year":"2023","unstructured":"Pires M, Rego AC (2023) Apoe4 and Alzheimer\u2019s disease pathogenesis\u2014mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci 24:778","journal-title":"Int J Mol Sci"},{"key":"6009_CR33","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","volume":"13","author":"M Di Battista","year":"2016","unstructured":"Di Battista M, Heinsinger M, Rebeck W (2016) Alzheimer\u2019s disease genetic risk factor APOE-\u03b54 also affects normal brain function. Curr Alzheimer Res 13:1200\u20131207","journal-title":"Curr Alzheimer Res"},{"key":"6009_CR34","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS et al (2017) Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci 20:1236\u20131246","journal-title":"Nat Neurosci"},{"key":"6009_CR35","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.abp9556","volume":"381","author":"S Balusu","year":"1979","unstructured":"Balusu S, Horr\u00e9 K, Thrupp N et al (1979) MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Science 381:1176\u20131182","journal-title":"Science"},{"key":"6009_CR36","doi-asserted-by":"publisher","first-page":"35532","DOI":"10.1074\/jbc.M807656200","volume":"283","author":"ME Shawgo","year":"2008","unstructured":"Shawgo ME, Shelton SN, Robertson JD (2008) Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells. J Biol Chem 283:35532\u201335538","journal-title":"J Biol Chem"},{"key":"6009_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13020240","volume":"13","author":"C Peggion","year":"2024","unstructured":"Peggion C, Cal\u00ec T, Brini M (2024) Mitochondria dysfunction and neuroinflammation in neurodegeneration: who comes first? Antioxidants 13:240","journal-title":"Antioxidants"},{"key":"6009_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101503","volume":"72","author":"T Song","year":"2021","unstructured":"Song T, Song X, Zhu C et al (2021) Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev 72:101503","journal-title":"Ageing Res Rev"},{"key":"6009_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111598","volume":"11","author":"A Pal","year":"2021","unstructured":"Pal A, Rani I, Pawar A et al (2021) Microglia and astrocytes in Alzheimer\u2019s disease in the context of the aberrant copper homeostasis hypothesis. Biomolecules 11:1598","journal-title":"Biomolecules"},{"key":"6009_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2025.168967","volume":"437","author":"J Fleming","year":"2025","unstructured":"Fleming J, Magana P, Nair S et al (2025) AlphaFold protein structure database and 3D-beacons: new data and capabilities. J Mol Biol 437:168967","journal-title":"J Mol Biol"},{"key":"6009_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbaf015","author":"Z Fang","year":"2025","unstructured":"Fang Z, Ran H, Zhang Y et al (2025) AlphaFold 3: an unprecedent opportunity for fundamental research and drug development. Precis Clin Med. https:\/\/doi.org\/10.1093\/pcmedi\/pbaf015","journal-title":"Precis Clin Med"},{"key":"6009_CR42","doi-asserted-by":"publisher","DOI":"10.1117\/1.NPh.11.3.034311","author":"SA Pierce","year":"2024","unstructured":"Pierce SA, Jacobelli J, Given KS et al (2024) OpenSTED: open-source dynamic intensity minimum system for stimulated emission depletion microscopy. Neurophotonics. https:\/\/doi.org\/10.1117\/1.NPh.11.3.034311","journal-title":"Neurophotonics"},{"key":"6009_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41377-023-01204-4","volume":"12","author":"X Chen","year":"2023","unstructured":"Chen X, Zhong S, Hou Y et al (2023) Superresolution structured illumination microscopy reconstruction algorithms: a review. Light Sci Appl 12:172","journal-title":"Light Sci Appl"},{"key":"6009_CR44","doi-asserted-by":"publisher","DOI":"10.1117\/1.NPh.12.S2.S22805","author":"M Zhao","year":"2025","unstructured":"Zhao M, Tanourlouee SB, McCracken S et al (2025) Genetically encoded biosensors of metabolic function for the study of neurodegeneration, a review and perspective. Neurophotonics. https:\/\/doi.org\/10.1117\/1.NPh.12.S2.S22805","journal-title":"Neurophotonics"},{"key":"6009_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112886","volume":"176","author":"W Liu","year":"2021","unstructured":"Liu W, Qiao Q, Zheng J et al (2021) An assembly-regulated SNAP-tag fluorogenic probe for long-term super-resolution imaging of mitochondrial dynamics. Biosens Bioelectron 176:112886","journal-title":"Biosens Bioelectron"},{"key":"6009_CR46","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1021\/acscentsci.5c00695","volume":"11","author":"X Lin","year":"2025","unstructured":"Lin X, Pang X, Huang Y et al (2025) Illuminating mitochondrial dynamics: ultrahigh labeling stability probe for long-term SIM super-resolution imaging of mitochondria. ACS Cent Sci 11:1700\u20131714","journal-title":"ACS Cent Sci"},{"key":"6009_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2022.102595","volume":"104","author":"C Bastian","year":"2022","unstructured":"Bastian C, Sampieri A, Benavides MO et al (2022) Super-resolution microscopy for the study of store-operated calcium entry. Cell Calcium 104:102595","journal-title":"Cell Calcium"},{"key":"6009_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1455153","author":"YdelasM Zulueta Diaz","year":"2024","unstructured":"Zulueta Diaz YdelasM, Arnspang EC (2024) Super-resolution microscopy to study membrane nanodomains and transport mechanisms in the plasma membrane. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2024.1455153","journal-title":"Front Mol Biosci"},{"key":"6009_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1591796","author":"M Cardillo","year":"2025","unstructured":"Cardillo M, Katam K, Suravajhala P (2025) Advancements in multi-omics research to address challenges in Alzheimer\u2019s disease: a systems biology approach utilizing molecular biomarkers and innovative strategies. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2025.1591796","journal-title":"Front Aging Neurosci"},{"key":"6009_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1065904","author":"C Clark","year":"2022","unstructured":"Clark C, Rabl M, Dayon L et al (2022) The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer\u2019s disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.1065904","journal-title":"Front Aging Neurosci"},{"key":"6009_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fninf.2024.1348113","author":"\u00c9 Chamberland","year":"2024","unstructured":"Chamberland \u00c9, Moravveji S, Doyon N et al (2024) A computational model of Alzheimer\u2019s disease at the nano, micro, and macroscales. Front Neuroinform. https:\/\/doi.org\/10.3389\/fninf.2024.1348113","journal-title":"Front Neuroinform"},{"key":"6009_CR52","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9044","author":"M Hassan","year":"2018","unstructured":"Hassan M, Abbas Q, Seo S et al (2018) Computational modeling and biomarker studies of pharmacological treatment of Alzheimer\u2019s disease (Review). Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2018.9044","journal-title":"Mol Med Rep"},{"key":"6009_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/15265161.2024.2416133","volume":"25","author":"S Iglesias","year":"2025","unstructured":"Iglesias S, Earp BD, Voinea C et al (2025) Digital doppelg\u00e4ngers and lifespan extension: what matters? Am J Bioeth 25:95\u2013110","journal-title":"Am J Bioeth"},{"key":"6009_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bosn.2024.09.001","volume":"2","author":"AZ Abijo","year":"2024","unstructured":"Abijo AZ, Olatunji SY, Adelodun ST et al (2024) Modeling Alzheimer\u2019s disease using cerebral organoids: current challenges and prospects. Brain Organoid Syst Neurosci J 2:53\u201363","journal-title":"Brain Organoid Syst Neurosci J"},{"key":"6009_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1553642","author":"C Dolciotti","year":"2025","unstructured":"Dolciotti C, Righi M, Grecu E et al (2025) The translational power of Alzheimer\u2019s-based organoid models in personalized medicine: an integrated biological and digital approach embodying patient clinical history. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2025.1553642","journal-title":"Front Cell Neurosci"},{"key":"6009_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0325-5","volume":"14","author":"F M\u00e1rquez","year":"2019","unstructured":"M\u00e1rquez F, Yassa MA (2019) Neuroimaging biomarkers for Alzheimer\u2019s disease. Mol Neurodegener 14:21","journal-title":"Mol Neurodegener"},{"key":"6009_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030061","volume":"10","author":"C Villa","year":"2020","unstructured":"Villa C, Lavitrano M, Salvatore E et al (2020) Molecular and imaging biomarkers in Alzheimer\u2019s disease: a focus on recent insights. J Pers Med 10:61","journal-title":"J Pers Med"},{"key":"6009_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2023.100063","volume":"8","author":"JE Georgakas","year":"2023","unstructured":"Georgakas JE, Howe MD, Thompson LI et al (2023) Biomarkers of Alzheimer\u2019s disease: past, present and future clinical use. Biomark Neuropsychiatry 8:100063","journal-title":"Biomark Neuropsychiatry"},{"key":"6009_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102591","volume":"10","author":"S Akyol","year":"2021","unstructured":"Akyol S, Ugur Z, Yilmaz A et al (2021) Lipid profiling of Alzheimer\u2019s disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism. Cells 10:2591","journal-title":"Cells"},{"key":"6009_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01777-5","author":"X Gao","year":"2025","unstructured":"Gao X, Cheng X, Chen P et al (2025) Plasma lipidomic fingerprinting enables high-accuracy biomarker discovery for Alzheimer\u2019s disease: a targeted LC-MRM\/MS approach. Geroscience. https:\/\/doi.org\/10.1007\/s11357-025-01777-5","journal-title":"Geroscience"},{"key":"6009_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105706","volume":"115","author":"W Liu","year":"2025","unstructured":"Liu W, Hu X, Bao Z et al (2025) Serum metabolic fingerprints encode functional biomarkers for ovarian cancer diagnosis: a large-scale cohort study. EBioMedicine 115:105706","journal-title":"EBioMedicine"},{"key":"6009_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12944-024-02396-3","volume":"24","author":"S Gurjar","year":"2025","unstructured":"Gurjar S, Bhat AR, Upadhya R et al (2025) Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective. Lipids Health Dis 24:5","journal-title":"Lipids Health Dis"},{"key":"6009_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biom11030388","volume":"11","author":"RCC de Freitas","year":"2021","unstructured":"de Freitas RCC, Hirata RDC, Hirata MH et al (2021) Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules 11:388","journal-title":"Biomolecules"},{"key":"6009_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/membranes15090263","volume":"15","author":"TT Truong","year":"2025","unstructured":"Truong TT, Singh AA, Bang NV et al (2025) Mitochondria-associated membrane dysfunction in neurodegeneration and its effects on lipid metabolism, calcium signaling, and cell fate. Membranes 15:263","journal-title":"Membranes"},{"key":"6009_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101846","author":"T Liu","year":"2025","unstructured":"Liu T, Rong Z, Li J et al (2025) Three-dimensional interactive network: mitochondrial-metabolic-calcium homeostasis driving Alzheimer\u2019s disease. Genes Dis. https:\/\/doi.org\/10.1016\/j.gendis.2025.101846","journal-title":"Genes Dis"},{"key":"6009_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.920228","author":"G Dentoni","year":"2022","unstructured":"Dentoni G, Castro-Aldrete L, Naia L et al (2022) The potential of small molecules to modulate the mitochondria\u2013endoplasmic reticulum interplay in Alzheimer\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2022.920228","journal-title":"Front Cell Dev Biol"},{"key":"6009_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061409","volume":"13","author":"N Drewes","year":"2025","unstructured":"Drewes N, Fang X, Gupta N et al (2025) Pharmacological and pathological implications of sigma-1 receptor in neurodegenerative diseases. Biomedicines 13:1409","journal-title":"Biomedicines"},{"key":"6009_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/acsptsci.4c00564","volume":"8","author":"MM Shokr","year":"2025","unstructured":"Shokr MM, Badawi GA, Elshazly SM et al (2025) Sigma 1 receptor and its pivotal role in neurological disorders. ACS Pharmacol Transl Sci 8:47\u201365","journal-title":"ACS Pharmacol Transl Sci"},{"key":"6009_CR69","first-page":"4808","volume":"8","author":"J-L Jin","year":"2015","unstructured":"Jin J-L, Fang M, Zhao Y-X et al (2015) Roles of sigma-1 receptors in Alzheimer\u2019s disease. Int J Clin Exp Med 8:4808\u20134820","journal-title":"Int J Clin Exp Med"},{"key":"6009_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00862","author":"DA Ryskamp","year":"2019","unstructured":"Ryskamp DA, Korban S, Zhemkov V et al (2019) Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00862","journal-title":"Front Neurosci"},{"key":"6009_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071637","volume":"9","author":"AP Magalh\u00e3es Rebelo","year":"2020","unstructured":"Magalh\u00e3es Rebelo AP, Dal Bello F, Knedlik T et al (2020) Chemical modulation of mitochondria\u2013endoplasmic reticulum contact sites. Cells 9:1637","journal-title":"Cells"},{"key":"6009_CR72","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Su T-P (2007) Sigma-1 receptor chaperones at the ER- mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131:596\u2013610","journal-title":"Cell"},{"key":"6009_CR73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/jcb.200307010","volume":"164","author":"Y Li","year":"2004","unstructured":"Li Y, Camacho P (2004) Ca2+-dependent redox modulation of SERCA 2b by ERp57. J Cell Biol 164:35\u201346","journal-title":"J Cell Biol"},{"key":"6009_CR74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/JAD-151189","volume":"54","author":"M Calvo-Rodr\u00edguez","year":"2016","unstructured":"Calvo-Rodr\u00edguez M, Garc\u00eda-Durillo M, Villalobos C et al (2016) Aging enables Ca2+ overload and apoptosis induced by amyloid-\u03b2 oligomers in rat hippocampal neurons: neuroprotection by non-steroidal anti-inflammatory drugs and R-flurbiprofen in aging neurons. J Alzheimers Dis 54:207\u2013221","journal-title":"J Alzheimers Dis"},{"key":"6009_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051236","volume":"10","author":"J Burillo","year":"2021","unstructured":"Burillo J, Marqu\u00e9s P, Jim\u00e9nez B et al (2021) Insulin resistance and diabetes mellitus in Alzheimer\u2019s disease. Cells 10:1236","journal-title":"Cells"},{"key":"6009_CR76","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.200106025","volume":"155","author":"J Teng","year":"2001","unstructured":"Teng J, Takei Y, Harada A et al (2001) Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J Cell Biol 155:65\u201376","journal-title":"J Cell Biol"},{"key":"6009_CR77","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1021\/acs.jmedchem.4c01368","volume":"68","author":"M Etxebeste-Mitxeltorena","year":"2025","unstructured":"Etxebeste-Mitxeltorena M, Flores-Romero H, Ramos-Inza S et al (2025) Modulation of mitochondria\u2013endoplasmic reticulum contacts (MERCs) by small molecules as a new strategy for restoring lipid metabolism in an amyotrophic lateral sclerosis model. J Med Chem 68:1179\u20131194","journal-title":"J Med Chem"},{"key":"6009_CR78","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40263-023-01007-6","volume":"37","author":"DS Malar","year":"2023","unstructured":"Malar DS, Thitilertdecha P, Ruckvongacheep KS et al (2023) Targeting sigma receptors for the treatment of neurodegenerative and neurodevelopmental disorders. CNS Drugs 37:399\u2013440","journal-title":"CNS Drugs"},{"key":"6009_CR79","doi-asserted-by":"publisher","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","volume":"63","author":"N Ye","year":"2020","unstructured":"Ye N, Qin W, Tian S et al (2020) Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases. J Med Chem 63:15187\u201315217","journal-title":"J Med Chem"},{"key":"6009_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00862","author":"DA Ryskamp","year":"2019","unstructured":"Ryskamp DA, Korban S, Zhemkov V et al (2019) Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00862","journal-title":"Front Neurosci"},{"key":"6009_CR81","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nbd.2013.10.010","volume":"62","author":"M Peviani","year":"2014","unstructured":"Peviani M, Salvaneschi E, Bontempi L et al (2014) Neuroprotective effects of the sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol Dis 62:218\u2013232","journal-title":"Neurobiol Dis"},{"key":"6009_CR82","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/syn.21549","volume":"66","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hayashi T, Urfer R et al (2012) Sigma\u20101 receptor chaperones regulate the secretion of brain\u2010derived neurotrophic factor. Synapse 66:630\u2013639","journal-title":"Synapse"},{"key":"6009_CR83","doi-asserted-by":"publisher","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","volume":"32","author":"B Oul\u00e8s","year":"2012","unstructured":"Oul\u00e8s B, Del Prete D, Greco B et al (2012) Ryanodine receptor blockade reduces amyloid-\u03b2 load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci 32:11820\u201311834","journal-title":"J Neurosci"},{"key":"6009_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.920228","author":"G Dentoni","year":"2022","unstructured":"Dentoni G, Castro-Aldrete L, Naia L et al (2022) The potential of small molecules to modulate the mitochondria\u2013endoplasmic reticulum interplay in Alzheimer\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2022.920228","journal-title":"Front Cell Dev Biol"},{"key":"6009_CR85","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjp.0706932","volume":"149","author":"G de J Garc\u00eda\u2010Rivas","year":"2006","unstructured":"de J Garc\u00eda\u2010Rivas G, Carvajal K, Correa F et al (2006) Ru 360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post\u2010ischaemic functional recovery in rats in vivo. Br J Pharmacol 149:829\u2013837","journal-title":"Br J Pharmacol"},{"key":"6009_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00329-7","volume":"11","author":"A Verma","year":"2022","unstructured":"Verma A, Shteinfer-Kuzmine A, Kamenetsky N et al (2022) Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer\u2019s disease protects against mitochondrial dysfunction and mitigates brain pathology. Transl Neurodegener 11:58","journal-title":"Transl Neurodegener"},{"key":"6009_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06605-0","volume":"23","author":"Y Guan","year":"2025","unstructured":"Guan Y, Li L, Yang R et al (2025) Targeting mitochondria with natural polyphenols for treating neurodegenerative diseases: a comprehensive scoping review from oxidative stress perspective. J Transl Med 23:572","journal-title":"J Transl Med"},{"key":"6009_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8100195","author":"S Fakhri","year":"2022","unstructured":"Fakhri S, Abbaszadeh F, Moradi SZ et al (2022) Effects of polyphenols on oxidative stress, inflammation, and interconnected pathways during spinal cord injury. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/8100195","journal-title":"Oxid Med Cell Longev"},{"key":"6009_CR89","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1017\/jns.2017.48","volume":"6","author":"M Singh","year":"2017","unstructured":"Singh M, Ramassamy C (2017) In vitro screening of neuroprotective activity of Indian medicinal plant Withania somnifera. J Nutr Sci 6:e54","journal-title":"J Nutr Sci"},{"key":"6009_CR90","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s10787-024-01461-8","volume":"32","author":"M Abomosallam","year":"2024","unstructured":"Abomosallam M, Hendam BM, Abdallah AA et al (2024) Neuroprotective effect of Withania somnifera leaves extract nanoemulsion against penconazole-induced neurotoxicity in albino rats via modulating TGF-\u03b21\/Smad2 signaling pathway. Inflammopharmacology 32:1903\u20131928","journal-title":"Inflammopharmacology"},{"key":"6009_CR91","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.3390\/biomedicines10123025","volume":"10","author":"N Arnst","year":"2022","unstructured":"Arnst N, Redolfi N, Lia A et al (2022) Mitochondrial Ca2+ signaling and bioenergetics in Alzheimer\u2019s disease. Biomedicines 10:3025","journal-title":"Biomedicines"},{"key":"6009_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1158204","author":"Z Li","year":"2023","unstructured":"Li Z, Cao Y, Pei H et al (2023) The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer\u2019s disease and the potential countermeasure. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2023.1158204","journal-title":"Front Neurosci"},{"key":"6009_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-025-04451-x","volume":"15","author":"LS Mathew","year":"2025","unstructured":"Mathew LS, Marathe A, Aman A et al (2025) Bridging the molecular and clinical aspects of resveratrol in Alzheimer\u2019s disease: a review. 3 Biotech 15:284","journal-title":"3 Biotech"},{"key":"6009_CR94","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/ptr.8200","volume":"38","author":"E Azzini","year":"2024","unstructured":"Azzini E, Pe\u00f1a-Corona SI, Hern\u00e1ndez-Parra H et al (2024) Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer\u2019s disease: targeting neuroinflammation strategies. Phytother Res 38:3169\u20133189","journal-title":"Phytother Res"},{"key":"6009_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"Salehi B, Mishra AP, Nigam M et al (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6:91","journal-title":"Biomedicines"},{"key":"6009_CR96","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"S Hewlings","year":"2017","unstructured":"Hewlings S, Kalman D (2017) Curcumin: a review of its effects on human health. Foods 6:92","journal-title":"Foods"},{"key":"6009_CR97","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2019.12.034","volume":"319","author":"D Gopalan","year":"2020","unstructured":"Gopalan D, Pandey A, Udupa N et al (2020) Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: role of surface engineered nanocarriers. J Control Release 319:183\u2013200","journal-title":"J Control Release"},{"key":"6009_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500521","author":"YT Goo","year":"2025","unstructured":"Goo YT, Grigoriev V, Korzun T et al (2025) Blood\u2010brain barrier\u2010penetrating nanocarriers enable microglial\u2010specific drug delivery in hypothalamic neuroinflammation. Adv Healthc Mater. https:\/\/doi.org\/10.1002\/adhm.202500521","journal-title":"Adv Healthc Mater"},{"key":"6009_CR99","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.2147\/IJN.S333657","volume":"16","author":"BS Alotaibi","year":"2021","unstructured":"Alotaibi BS, Buabeid M, Ibrahim NA et al (2021) Potential of nanocarrier-based drug delivery systems for brain targeting: a current review of literature. Int J Nanomedicine 16:7517\u20137533","journal-title":"Int J Nanomedicine"},{"key":"6009_CR100","first-page":"450","volume":"28","author":"E Konstantinidis","year":"2022","unstructured":"Konstantinidis E, Molisak A, Perrin F et al (2022) CRISPR-Cas9 treatment partially restores amyloid-\u03b2 42\/40 in human fibroblasts with the Alzheimer\u2019s disease PSEN1 M146L mutation. Mol Ther 28:450\u2013461","journal-title":"Mol Ther"},{"key":"6009_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.699597","author":"SA Abdelnour","year":"2021","unstructured":"Abdelnour SA, Xie L, Hassanin AA et al (2021) The potential of CRISPR\/Cas9 gene editing as a treatment strategy for inherited diseases. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.699597","journal-title":"Front Cell Dev Biol"},{"key":"6009_CR102","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","volume":"11","author":"B Gy\u00f6rgy","year":"2018","unstructured":"Gy\u00f6rgy B, L\u00f6\u00f6v C, Zaborowski MP et al (2018) CRISPR\/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer\u2019s disease. Mol Ther Nucleic Acids 11:429\u2013440","journal-title":"Mol Ther Nucleic Acids"},{"key":"6009_CR103","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 31:397\u2013405","journal-title":"Trends Biotechnol"},{"key":"6009_CR104","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18:358\u2013378","journal-title":"Nat Rev Drug Discov"},{"key":"6009_CR105","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C et al (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31:822\u2013826","journal-title":"Nat Biotechnol"},{"key":"6009_CR106","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","volume":"26","author":"B Kantor","year":"2018","unstructured":"Kantor B, Tagliafierro L, Gu J et al (2018) Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD. Mol Ther 26:2638\u20132649","journal-title":"Mol Ther"},{"key":"6009_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.589319","author":"OM Shirokova","year":"2020","unstructured":"Shirokova OM, Pchelin PV, Mukhina IV (2020) MERCs. The novel assistant to neurotransmission? Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.589319","journal-title":"Front Neurosci"},{"key":"6009_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2017.00107","author":"N Ilacqua","year":"2017","unstructured":"Ilacqua N, S\u00e1nchez-\u00c1lvarez M, Bachmann M et al (2017) Protein localization at mitochondria-ER contact sites in basal and stress conditions. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2017.00107","journal-title":"Front Cell Dev Biol"},{"key":"6009_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05286-0","volume":"81","author":"JC Casas-Martinez","year":"2024","unstructured":"Casas-Martinez JC, Samali A, McDonagh B (2024) Redox regulation of UPR signalling and mitochondrial ER contact sites. Cell Mol Life Sci 81:250","journal-title":"Cell Mol Life Sci"},{"key":"6009_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111853","volume":"22","author":"C Peggion","year":"2021","unstructured":"Peggion C, Massimino ML, Bonadio RS et al (2021) Regulation of endoplasmic reticulum\u2013mitochondria tethering and Ca2+ fluxes by TDP-43 via GSK3\u03b2. Int J Mol Sci 22:11853","journal-title":"Int J Mol Sci"},{"key":"6009_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102289","volume":"52","author":"M Yuan","year":"2022","unstructured":"Yuan M, Gong M, He J et al (2022) IP3R1\/GRP75\/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling. Redox Biol 52:102289","journal-title":"Redox Biol"},{"key":"6009_CR112","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12882-018-0940-3","volume":"19","author":"H Xu","year":"2018","unstructured":"Xu H, Guan N, Ren Y-L et al (2018) IP3R-Grp75-VDAC1-MCU calcium regulation axis antagonists protect podocytes from apoptosis and decrease proteinuria in an Adriamycin nephropathy rat model. BMC Nephrol 19:140","journal-title":"BMC Nephrol"},{"key":"6009_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102320","volume":"98","author":"T Jiang","year":"2024","unstructured":"Jiang T, Ruan N, Luo P et al (2024) Modulation of ER-mitochondria tethering complex VAPB-PTPIP51: novel therapeutic targets for aging-associated diseases. Ageing Res Rev 98:102320","journal-title":"Ageing Res Rev"},{"key":"6009_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071637","volume":"9","author":"AP Magalh\u00e3es Rebelo","year":"2020","unstructured":"Magalh\u00e3es Rebelo AP, Dal Bello F, Knedlik T et al (2020) Chemical modulation of mitochondria\u2013endoplasmic reticulum contact sites. Cells 9:1637","journal-title":"Cells"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06009-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:03:42Z","timestamp":1781777022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06009-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6009"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06009-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve any animal or human subjects. There are no ethical considerations to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This study does not involve any human subjects. There is no consent to participate necessary for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"We declare that this manuscript does not contain any person\u2019s data in any form (including identifiable images, clinical details, or personal identifiers). As no human participants, patient data, or identifiable biological material was used in this review, consent for publication is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"701"}}